VoyForums: Hepatitis C Outreach Project

Support VoyForums by visiting our sponsor, www.PainEase.com.

Sat, May 18 2013, 17:17:01 PDT [ VoyUser Login optional ] [ Main index ] [ Post a new message ] [ Search | Check update time | Archives: [1], 2, 3, 4, 5 ]

Hepatitis C Outreach Project, (since 1992) Discussion Forum
Our mission is to inspire, support and enhance community efforts toward prevention, awareness, education, and treatment of hepatitis C and promote organ donation. We are committed to working with any organization, agency, or professional individual to develop partnerships resulting in quality programing and good public decision making based on accurate information regarding hepatitis C. We offer our resources and services freely in a spirit of goodwill and generosity, ever mindful of our purpose.

Information on health issues concerning hepatitis C. The information is intended to assist professionals with clinical decisions and provide background information for presentations. It is not intended as a substitute for medical advice from a practitioner.
Please remember the Hepatitis C Outreach Project in your Workplace Giving Campaigns this fall
As fall is upon us, so too are the workplace fund drives. Hepatitis C is proud to participate in employee giving programs that allow donations through payroll deduction.
Please consider Hepatitis C when making your contribution this fall.
Many state governments have charitable fund drives for their employees. Each state has its own eligibility criteria. If you wish to designate the Hepatitis C Outreach Project for your contributions and your state requires information or documentation, please contact us and let us know what we need to do to qualify for your fund drive.
Some United Way campaigns allow unlisted charities to receive your contribution. If Hepatitis C Outreach Project is not listed in your United Way brochure, you may still be able to contribute through the "Donor Option" feature that many local United Ways now offer. If your local has the donor option, write the Hepatitis C Outreach name and address in the space provided on your United Way pledge card:
Hepatitis C Outreach Project
Tax ID: 91-1909632

Finally, many corporate giving campaigns allow a donor to write in a charity of choice. Lists are often provided of eligible organizations, but the list is not limited. You can still designate the Hepatitis C Outreach Project as your choice this year simply by writing the above information into the space provided.
The Hepatitis C Outreach Project is very grateful for our past contributors and we hope that you will continue to support our mission in the fall 2009 pledge drive in your community.
We are a 501(c)3 charitable organization under the Internal Revenue Service Tax Code. We are listed with Guidestar.org, verified by facebook.
Back to HCOP site

Subject	Author	Date
Nosocomial transmission of bloodborne viruses from infected health care workers to patients	Lynn Johnston MD1, John M Conly MD2; Canadian Journal of Infectious Diseases,July/August 2003, Volume 14, Number 4: 192	Wed, September 17 2003, 5:43:10 PDT
Longitudinal Study of Newly Acquired Hepatitis C Infection Among Injecting Drug Users	Jauncey M1 Gilmour S,2 Micallef J3, van Beek I2, White P,4Rawlinson W,4	Wed, September 17 2003, 5:26:55 PDT
High body mass index is a risk factor for nonresponse to treatment in hepatitis C	Bressler, B; Hepatology 2003; 38: 639-44 04 September 2003	Wed, September 03 2003, 18:24:40 PDT
Cost-effectiveness of Treatment for Chronic Hepatitis C Infection in an Evolving Patient Population	Joshua A. Salomon, PhD; Milton C. Weinstein, PhD; James K. Hammitt, PhD; Sue J. Goldie, MD, MPH; JAMA. 2003;290:228-237.	Fri, August 22 2003, 7:17:54 PDT
Association of Funding and Conclusions in Randomized Drug Trials	Bodil Als-Nielsen, MD, et al;JAMA. 2003;290:921-928	Fri, August 22 2003, 7:06:29 PDT
Hepatitis C infection among patients receiving hemodialysis	Kamar N, et al; Nephrologie. 2003;24(3):133-41.	Wed, August 20 2003, 14:10:35 PDT
Downside to Fewer Violent Deaths: Transplant Organ Shortage Grows	RICHARD PIREZ-PEQA; http://www.nytimes.com/2003/08/19/health/19DONO.html?th	Tue, August 19 2003, 10:31:22 PDT
American Gastroenterological Association survey results	Funded by Hoffman-LaRoche	Mon, August 18 2003, 11:52:02 PDT
Five abstracts on Pegasys (Roche)	Digestive Diseases Week, May 19-21, 2002	Mon, May 20 2002, 8:38:43 PDT
Press Release: Pegasys Potentially a major advance in Hepatitis B treatment -- Results phase II study (2002 Asian Pac Assoc Study Liver), Mon, September 30 2002, 8:17:27 PDT FDA Approves PegasysÒ (peginterferon alfa-2a) in Combination with Copegus™ (ribavirin) for the Treatment of Hepatitis C -- Press Release/ Roche, Tue, December 03 2002, 23:04:30 PST ROCHE: News Release January 13, 2003 -- Pamela Van Houten (Roche), Mon, January 13 2003, 14:04:27 PST FDA Transcript on Pegasys; Everything you Need to know about Interferon Treatment -- T Hanbey, Hepatitis C Outreach Project, Wed, August 13 2003, 1:33:44 PDT
HCV Viremia at Delivery a Risk Factor for Mother-to-Infant	Pediatr Infect Dis J 2001;20:10-14.	Sat, March 03 2001, 15:45:53 PST
Maternal Injection Drug Use Increases Risk of Vertical Hepatitis C Transmission -- J Infect Dis 2002;185:567-572., Thu, January 02 2003, 19:15:48 PST Guidelines for the Screening and Follow-up of Infants Born to anti-HCV Positive Mothers -- M Resti and others (for the Committee of Hepatology of the Italian Society of Pediatric Gastroenterology and Hepatology);Digestive Liver Disease 35(7): 453-457. July 2003, Sun, August 10 2003, 7:27:03 PDT Vaginal laceration is a risk factor for HCV transmission in childbirth -- Holzmann,H et al;J Infect Dis. 2003:187:345-351, Sun, August 10 2003, 7:29:35 PDT Vaginal laceration is a risk factor for HCV transmission in childbirth -- Holzmann, M, et al; J Infect Dis. 2003:187:345-351, Sun, August 10 2003, 7:49:18 PDT
Smoking and alcohol consumption are independently associated with disease progression	Arch Intern Med 2002	Wed, April 17 2002, 7:52:29 PDT
Patients With Hepatitis C Must Be Discouraged From Drinking Alcohol -- Review: Lancet Infect Dis 2002; 2: 303-09, Wed, May 22 2002, 5:10:45 PDT Moderate alcohol intake increases fibrosis progression in untreated patients with HCV infection -- J. Westin, et al, Wed, June 12 2002, 3:30:42 PDT Alcohol potentiates hepatitis C virus replicon expression -- Zhang T, Li Y, et al Hepatology. 2003 Jul;38(1):57-65, Sun, July 13 2003, 11:40:51 PDT ALCOHOL INCREASES HEPATITIS C VIRUS IN HUMAN CELLS -- U.S. Department of Health and Human Services, Sun, July 13 2003, 12:06:56 PDT Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C. -- Rigamonti C, Mottaran E,: Hepatology. 2003 Jul;38(1):42-9., Sun, July 13 2003, 12:10:00 PDT Alcohol ups hepatitis C virus replication and it interferes with the effectiveness of interferon used to treat hepatitis C -- Ho, etal, Hepatology, July 2003, Sun, August 10 2003, 7:39:46 PDT
Rates and risk factors of liver fibrosis progression	J. Hepatol. (2001) 34(5): 730-9	Mon, July 30 2001, 8:06:13 PDT
Biochemical markers of liver fibrosis in patients infected by hepatitis C virus -- Poynard T (J Viral Hepat 2002 Mar;9(2):128-133 ), Tue, March 12 2002, 8:01:12 PST Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model -- Deuffic-Burban S (J Viral Hepat 2002 Mar;9(2):114-122 ), Tue, March 12 2002, 10:15:12 PST Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting... -- Neuman MG (J Viral Hepat 2002 Mar;9(2):134-140), Tue, March 12 2002, 8:04:36 PST Is severe liver disease a common outcome for people with chronic hepatitisC? -- GJ Dore, et al. Journal of Gastroenterology and Hepatology, Wed, May 22 2002, 4:33:47 PDT Ongoing Interface Hepatitis C May Signal More Fibrosis Later -- DG review:Liver, Volume 22 Issue 2 Page 136, Wed, July 24 2002, 11:28:56 PDT Does High Body Mass Index Affect Hepatic Fibrosis, Steatosis and Inflammation in Patients with Chronic Hepatitis C? -- Metwally, et al; Mayo Clinic, Rochester, MN, Sat, January 04 2003, 10:57:58 PST Progression of fibrosis in chronic hepatitis C -- Ghany M; Gastroenterology 2003; 124(1): 97-104, Tue, January 07 2003, 6:31:39 PST Hepatitis C virus RNA quantitation in hepatic veins and peripheral blood in patients with liver cirrhosis: evidence for low level intrahepatic hepatitis C virus replication in advanced liver disease. -- Puoti C, et al Dig Liver Dis 2002 Nov;34(11):802-7, Wed, February 05 2003, 8:23:36 PST Risk factors for Level 3 fibrosis and high viral count -- David M. Gillespie, Wed, March 12 2003, 10:47:10 PST Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT. -- Kyrlagkitsis I, et aAm J Gastroenterol. 2003 Jul;98(7):1588-93l, Wed, July 30 2003, 7:01:47 PDT Noninvasive index to predict fibrosis and cirrhosis in hepatitis C -- Chun-Tao Wai, et al; Hepatology 2003; 38: 518-26, Wed, July 30 2003, 7:30:30 PDT
Prospective study of mother-to-infant transmission of hepatitis C virus.	Tajiri H, et al	Tue, April 17 2001, 16:29:42 PDT
Guidelines for the screening and follow-up of infants born to anti-HCV positive mothers -- Resti M, et al; Dig Liver Dis. 2003 Jul;35(7):453-7, Wed, July 30 2003, 7:13:34 PDT
Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.	Gerlach JT, et al; Gastroenterology 2003;125:1:80-88.	Wed, July 30 2003, 6:53:13 PDT
The effects of lifestyle modification and vitamin E on cytokines and NASH	Kugelmas, M, et al: Hepatology 2003; 38: 413-19	Tue, July 29 2003, 7:24:55 PDT

[ Archives: [1], 2, 3, 4, 5 ]

If you have questions or wish to add to the articles, please contact us at info@hcop.org Check "archives" at upper right to access more information. Requests for specific reseach information by email:
info@hcop.org.

Forum timezone: GMT-8
VF Version: 2.94, ConfDB:
Before posting please read our privacy policy.
VoyForums^(tm) is a Free Service from Voyager Info-Systems.
Copyright © 1998-2012 Voyager Info-Systems. All Rights Reserved.